| [1] |
Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.
Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study
[J]. Journal of International Oncology, 2024, 51(6): 326-331.
|
| [2] |
Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.
Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer
[J]. Journal of International Oncology, 2024, 51(6): 332-337.
|
| [3] |
Gao Fan, Wang Ping, Du Chao, Chu Yanliu.
Research progress on intestinal flora and non-surgical treatment of the colorectal cancer
[J]. Journal of International Oncology, 2024, 51(6): 376-381.
|
| [4] |
Qian Xiaotao, Shi Ziyi, Hu Ge.
A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2024, 51(3): 151-156.
|
| [5] |
Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.
Progress of radiotherapy in oligometastatic non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(3): 170-174.
|
| [6] |
Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.
Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients
[J]. Journal of International Oncology, 2024, 51(1): 37-42.
|
| [7] |
Cui Tenglu, Lyu lu, Sun Pengfei.
Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma
[J]. Journal of International Oncology, 2023, 50(9): 548-552.
|
| [8] |
Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.
Research progress on the application of combining radiotherapy and systemic therapy in breast cancer
[J]. Journal of International Oncology, 2023, 50(6): 362-367.
|
| [9] |
Lyu Lu, Sun Pengfei.
Gut flora and cervical cancer
[J]. Journal of International Oncology, 2023, 50(6): 373-376.
|
| [10] |
Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.
Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version）
[J]. Journal of International Oncology, 2023, 50(4): 193-201.
|
| [11] |
Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.
Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance
[J]. Journal of International Oncology, 2023, 50(4): 227-230.
|
| [12] |
Shi Xaioqi, Wang Hongyan.
Research progress on the interaction between gut microbiota and radiation enteritis
[J]. Journal of International Oncology, 2023, 50(4): 244-247.
|
| [13] |
Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.
Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases
[J]. Journal of International Oncology, 2023, 50(3): 138-143.
|
| [14] |
Huang Huayu, Gong Hongyun, Song Qibin.
Influencing factors of pneumonitis in the period of thoracic radiotherapy combined with immunotherapy
[J]. Journal of International Oncology, 2023, 50(2): 102-106.
|
| [15] |
Cao Xiaohui, Yu Hong, Li Wanhu.
Application of CT-based radiomics analysis in predicting and identifying of treatment-associated pneumonitis
[J]. Journal of International Oncology, 2023, 50(2): 107-111.
|
